Valuation Genexine, Inc.

Stocks

End-of-day quote Korea S.E. 2026-08-14			5-day change	1st Jan Change
2,620.00 ^KRW	-0.19%		-0.76%	-44.08%

04-28	Genexine Inc Demonstrates First-In-Class Sox2 Degrader Gx-Bp1 in Preclinical Models	CI
03-16	Egret Therapeutics, Inc and Genexine, Inc Sign Memorandum Of Understanding For Asset Transfer Of GX-P1 (EGT-101)	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023
Market Cap ¹	1,485,081	3,069,933	1,459,198	470,211	410,353
Change	-	106.72%	-52.47%	-67.78%	-12.73%
Enterprise Value (EV) ¹	1,441,942	3,090,374	1,483,621	532,352	413,298
Change	-	114.32%	-51.99%	-64.12%	-22.36%
P/E	-80.7x	142x	-30.2x	-8.34x	-5.99x
PBR	5x	5.73x	2.84x	1.72x	1.38x
PEG	-	-1x	0x	-0.5x	1.44x
Capitalization / Revenue	131x	166x	39.6x	29.1x	92.7x
EV / Revenue	128x	167x	40.3x	33x	93.4x
EV / EBITDA	-34.3x	-85.3x	-93.9x	-18.5x	-11.2x
EV / EBIT	-32.4x	-78.9x	-77.7x	-15.8x	-9.86x
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	-595.4	671.5	-1,483	-1,724	-1,652
Distribution rate	-	-	-	-	-
Net sales ¹	11,303	18,543	36,828	16,139	4,427
EBITDA ¹	-42,070	-36,231	-15,801	-28,808	-36,897
EBIT ¹	-44,573	-39,151	-19,099	-33,680	-41,928
Net income ¹	-16,509	27,570	-48,042	-55,974	-66,874
Net Debt ¹	-43,139	20,441	24,423	62,141	2,945
Reference price ²	48,076.92	95,615.38	44,846.15	14,384.62	9,900.00
Nbr of stocks (in thousands)	30,890	32,107	32,538	32,688	41,450
Announcement Date	3/12/21	3/12/21	3/17/22	3/20/23	3/13/24

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GENEXINE, INC.	-	-	-	-	84.3M
WUXI APPTEC CO., LTD.	20.97x	7.34x	14.96x	1.41%	70.07B
ARGENX SE	30.34x	7.64x	23.38x	0.05%	52.87B
INSMED INCORPORATED	-78.21x	14.61x	-74.55x	-.--%	27.02B
WUXI BIOLOGICS (CAYMAN) INC.	29.96x	5.86x	15.52x	-.--%	23.61B
BIONTECH SE	-14.6x	5.15x	-6.71x	-.--%	23.38B
PHARMAESSENTIA CORPORATION	60.41x	21.44x	43.75x	0.06%	19.43B
GENMAB A/S	25.59x	4.85x	16.27x	-.--%	18.75B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-802.92x	37.67x	-14929.22x	-.--%	15.85B
EXELIXIS, INC.	15.89x	4.68x	10.93x	-.--%	12.7B
Average	-79.17x	12.14x	-1,653.96x	0.17%	26.38B
Weighted average by Cap.	-36.21x	10.37x	-890.90x	0.39%